The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Novartis
Stock and Other Ownership Interests - Novartis
GEOMETRY duo-1: A phase (Ph) Ib/II, multicenter trial of oral cMET inhibitor capmatinib (INC280) ± erlotinib vs platinum + pemetrexed in adult patients (pts) with epidermal growth factor receptor (EGFR)-mutated, cMET-amplified, locally advanced/metastatic non-small cell lung cancer (NSCLC) with acquired resistance to prior EGFR tyrosine kinase inhibitor (TKI) therapy.
 
Egbert F. Smit
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Roche/Genentech (Inst)
 
Hans-Georg Kopp
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Sanofi
Expert Testimony - GlaxoSmithKline; LEO Pharma; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Lilly; Novartis; Sanofi
 
Dong-Wan Kim
No Relationships to Disclose
 
Giampaolo Tortora
Travel, Accommodations, Expenses - Celgene; Merck
 
Alexander I. Spira
Honoraria - Novartis; Roche
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; MedImmune; Roche
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Roche
 
Alfredo Berruti
No Relationships to Disclose
 
Dae Ho Lee
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pfizer; Samsung
 
Noemi Reguart
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Pfizer; Roche
Speakers' Bureau - Boehringer Ingelheim; Pfizer
Research Funding - Boehringer Ingelheim
Expert Testimony - Boehringer Ingelheim; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Igor I. Rybkin
No Relationships to Disclose
 
Mikhail Akimov
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Karl Maria Schumacher
No Relationships to Disclose
 
Allison Upalawanna
Employment - Novartis
 
Cindy Xu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Matthew Squires
Employment - Novartis
 
Daniel Shao-Weng Tan
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Novartis
Research Funding - Bayer; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Merck; Novartis